The Mantle network, a layer-2 blockchain on Ethereum, manages a treasury worth $2.25 billion, but only about $99 million is deposited on its own blockchain. This large gap shows that while the organization behind Mantle is financially strong, actual network usage remains modest. Mantle recently upgraded its technology to a ZK validity rollup for faster transaction finality and supports various products beyond the blockchain itself. European investors can buy its MNT token mainly on Kraken, but risks include high treasury concentration in MNT, limited trading venues, and significant token supply yet to enter the market. The network's future growth depends on increasing capital deposited on-chain rather than just treasury size.
The story about Mantle and its MNT token is presented here with Pluang's market context. For readers following major cryptocurrencies, here is Pluang's market snapshot as of Oct 14, 2026 22:02 WIB: out of 50 major cryptocurrencies priced on Pluang, 6 rose and 43 fell. Notable movers include SXP (Solar) down 46.27% at Rp37, BAL (Balancer) up 11.14% at Rp16.297, and ONE (Harmony) down 8.30% at Rp28 with a typical hold time of 152 days and a Pluang order activity split of 54% Sell to 46% Buy.
Jefferies has maintained a Buy rating on Big Yellow Group despite recent stock declines, citing the company's strong fundamentals including freehold properties and solid cash flows. Activist investor Ancora, holding over 4% of shares, is pushing Big ...
Fastenal reported strong Q3 2026 earnings, beating analyst expectations with EPS of $0.35 and revenue of $2.46 billion. The company saw a 20% rise in net income to $401.6 million and a 15.5% increase in revenue driven by robust manufacturing demand, ...
Remittix announced the public launch of its RTX token on November 24, 2026, marking the end of its presale phase which raised over $32 million from 40,000 participants. The project is testing its PayFi platform, which enables crypto-to-fiat and fiat-...
The global microbiology testing market is projected to grow rapidly at a compound annual growth rate (CAGR) of approximately 9% from 2026 to 2034, reaching a market size of $13.7 billion by 2034. This growth is driven by the rising prevalence of infe...
H.C. Wainwright raised its price target for Alector from $5.00 to $8.00, maintaining a Buy rating due to progress in its neurodegenerative disease pipeline. Alector develops treatments for Alzheimer's and Parkinson's using its Brain Carrier platform ...
